Logo image of HNGR

HANGER INC (HNGR) Stock Fundamental Analysis

NYSE:HNGR - New York Stock Exchange, Inc. - US41043F2083 - Common Stock - Currency: USD

18.72  0 (0%)

After market: 18.72 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HNGR. HNGR was compared to 103 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of HNGR have multiple concerns. HNGR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HNGR was profitable.
HNGR Yearly Net Income VS EBIT VS OCF VS FCFHNGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA 3.86%
ROE 29.78%
ROIC 7.59%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNGR Yearly ROA, ROE, ROICHNGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 100 -100 200 300

1.3 Margins

Industry RankSector Rank
OM 6.01%
PM (TTM) 3.17%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNGR Yearly Profit, Operating, Gross MarginsHNGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

HNGR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, HNGR has more shares outstanding
The debt/assets ratio for HNGR has been reduced compared to a year ago.
HNGR Yearly Shares OutstandingHNGR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
HNGR Yearly Total Debt VS Total AssetsHNGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.67, we must say that HNGR is in the distress zone and has some risk of bankruptcy.
HNGR has a Debt/Equity ratio of 3.71. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 3.71
Debt/FCF N/A
Altman-Z 1.67
ROIC/WACC1
WACC7.58%
HNGR Yearly LT Debt VS Equity VS FCFHNGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M 400M 500M

2.3 Liquidity

HNGR has a Current Ratio of 1.23. This is a normal value and indicates that HNGR is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 0.85 indicates that HNGR may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.85
HNGR Yearly Current Assets VS Current LiabilitesHNGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

HNGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
The earnings per share for HNGR have been decreasing by -11.45% on average. This is quite bad
The Revenue has grown by 11.72% in the past year. This is quite good.
HNGR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.46% yearly.
EPS 1Y (TTM)32%
EPS 3Y8.37%
EPS 5Y-11.45%
EPS Q2Q%29.63%
Revenue 1Y (TTM)11.72%
Revenue growth 3Y2.23%
Revenue growth 5Y1.46%
Sales Q2Q%11.12%

3.2 Future

HNGR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.17% yearly.
The Revenue is expected to grow by 4.78% on average over the next years.
EPS Next Y18.65%
EPS Next 2Y11.76%
EPS Next 3Y9.66%
EPS Next 5Y9.17%
Revenue Next Year7.98%
Revenue Next 2Y5.28%
Revenue Next 3Y4.6%
Revenue Next 5Y4.78%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HNGR Yearly Revenue VS EstimatesHNGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
HNGR Yearly EPS VS EstimatesHNGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.91 indicates a rather expensive valuation of HNGR.
HNGR is valuated rather cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 15.29, the valuation of HNGR can be described as correct.
HNGR is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.91
Fwd PE 15.29
HNGR Price Earnings VS Forward Price EarningsHNGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.51
HNGR Per share dataHNGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y11.76%
EPS Next 3Y9.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HNGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HANGER INC

NYSE:HNGR (9/30/2022, 8:25:44 PM)

After market: 18.72 0 (0%)

18.72

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-08 2022-08-08/amc
Earnings (Next)11-07 2022-11-07/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners0.76%
Ins Owner Change0%
Market Cap732.39M
Analysts80
Price Target23.84 (27.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.91
Fwd PE 15.29
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 5.85
P/tB N/A
EV/EBITDA 11.51
EPS(TTM)0.99
EY5.29%
EPS(NY)1.22
Fwd EY6.54%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS30.05
BVpS3.2
TBVpSN/A
PEG (NY)1.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.86%
ROE 29.78%
ROCE N/A
ROIC 7.59%
ROICexc N/A
ROICexgc 16.72%
OM 6.01%
PM (TTM) 3.17%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 3.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.85
Altman-Z 1.67
F-Score6
WACC7.58%
ROIC/WACC1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y8.37%
EPS 5Y-11.45%
EPS Q2Q%29.63%
EPS Next Y18.65%
EPS Next 2Y11.76%
EPS Next 3Y9.66%
EPS Next 5Y9.17%
Revenue 1Y (TTM)11.72%
Revenue growth 3Y2.23%
Revenue growth 5Y1.46%
Sales Q2Q%11.12%
Revenue Next Year7.98%
Revenue Next 2Y5.28%
Revenue Next 3Y4.6%
Revenue Next 5Y4.78%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A